0,855  0,002  Alcohol oxidase inhibitor
0,815  0,004  Cardiovascular analeptic
0,718  0,011  GST A substrate
0,712  0,005  AR expression inhibitor
0,658  0,005  Tumour necrosis factor alpha release inhibitor
0,625  0,016  Aldehyde oxidase inhibitor
0,595  0,008  GABA C receptor rho-3 antagonist
0,580  0,005  Septic shock treatment
0,583  0,016  5 Hydroxytryptamine release stimulant
0,567  0,004  Contraceptive
0,562  0,010  FMO1 substrate
0,548  0,003  GST M1-1 substrate
0,581  0,039  Caspase 9 stimulant
0,542  0,005  Alpha-N-acetylglucosaminidase inhibitor
0,534  0,017  UGT1A9 substrate
0,532  0,020  Sensitization
0,515  0,004  GABA C receptor agonist
0,548  0,036  Antineoplastic (solid tumors)
0,519  0,011  UDP-glucuronosyltransferase substrate
0,508  0,005  Endometrios treatment
0,506  0,005  Antiacne
0,522  0,027  Antipruritic, allergic
0,521  0,026  5 Hydroxytryptamine release inhibitor
0,502  0,008  Anesthetic general
0,530  0,039  TNF expression inhibitor
0,501  0,011  UGT2B4 substrate
0,508  0,021  Ulceration
0,505  0,019  Antineoplastic (brain cancer)
0,493  0,007  Prostatic (benign) hyperplasia treatment
0,488  0,004  Contraceptive male
0,488  0,005  5 Hydroxytryptamine uptake stimulant
0,503  0,028  Respiratory analeptic
0,473  0,006  Prostate disorders treatment
0,497  0,035  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,481  0,022  NOS3 expression inhibitor
0,489  0,034  Teratogen
0,490  0,036  Immunosuppressant
0,466  0,016  Eye irritation, high
0,484  0,034  Calcium channel L-type activator
0,465  0,017  Superoxide dismutase inhibitor
0,460  0,013  Peroxidase inhibitor
0,482  0,035  Cholesterol antagonist
0,456  0,010  Calcium channel activator
0,464  0,019  ICAM1 expression inhibitor
0,477  0,033  Embryotoxic
0,443  0,005  Growth factor agonist
0,432  0,010  Carcinogenic, group 3
0,449  0,028  CTGF expression inhibitor
0,425  0,005  Antidiabetic (type 1)
0,455  0,036  Bone diseases treatment
0,420  0,005  UDP-glucose 4-epimerase inhibitor
0,428  0,014  Antimutagenic
0,420  0,006  Tyrosine 3 hydroxylase inhibitor
0,418  0,007  Lipocortins synthesis antagonist
0,412  0,005  Interleukin 1 antagonist
0,454  0,048  Histamine release inhibitor
0,416  0,014  Abortion inducer
0,415  0,014  UGT1A4 substrate
0,489  0,092  Antiinflammatory
0,410  0,015  FMO3 substrate
0,422  0,033  Analeptic
0,401  0,014  Antiparkinsonian, rigidity relieving
0,428  0,047  Vasodilator, peripheral
0,380  0,001  RNA-directed RNA polymerase stimulant
0,421  0,044  Antiallergic
0,379  0,004  Opioid kappa receptor antagonist
0,383  0,010  GST P1-1 substrate
0,400  0,027  Interleukin 2 agonist
0,381  0,011  Pneumotoxic
0,388  0,019  RNA-directed DNA polymerase inhibitor
0,377  0,009  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,389  0,024  Psychostimulant
0,371  0,010  UGT2B15 substrate
0,397  0,037  Antineoplastic (glioma)
0,379  0,022  Flavin-containing monooxygenase substrate
0,415  0,058  CYP2C9 substrate
0,383  0,027  UGT1A6 substrate
0,359  0,004  Postmenopausal disorders treatment
0,363  0,008  Gastrin inhibitor
0,367  0,013  Antipruritic, non-allergic
0,353  0,004  Porphobilinogen synthase inhibitor
0,381  0,036  NOS2 expression inhibitor
0,361  0,016  UGT2B7 substrate
0,377  0,034  Interleukin antagonist
0,382  0,041  Antiosteoporotic
0,352  0,012  Acaricide
0,339  0,003  GST T1-1 substrate
0,357  0,022  UGT1A1 substrate
0,340  0,005  Estrogen receptor beta antagonist
0,398  0,064  Transcription factor NF kappa B inhibitor
0,433  0,099  Apoptosis agonist
0,351  0,020  Skin irritative effect
0,337  0,007  UGT2B9 substrate
0,357  0,027  Interleukin agonist
0,338  0,009  Glutathione S-transferase substrate
0,338  0,010  Neurotrophic factor enhancer
0,341  0,014  Cholinergic
0,343  0,017  Male reproductive disfunction treatment
0,362  0,037  Radiosensitizer
0,329  0,006  Excitatory amino acid transporter EAAC1 inhibitor
0,343  0,020  Antiviral (Influenza)
0,358  0,037  Carcinogenic
0,356  0,037  Antihypoxic
0,375  0,058  Prostate cancer treatment
0,321  0,008  Succinate dehydrogenase inhibitor
0,337  0,025  Muscle relaxant
0,315  0,004  Creatine kinase inhibitor
0,325  0,016  Hair growth stimulant
0,313  0,004  UGT2B10 substrate
0,314  0,006  Ferrochelatase inhibitor
0,353  0,050  CYP2C19 substrate
0,377  0,075  CYP2C19 inhibitor
0,309  0,009  SULT1A3 substrate
0,323  0,024  Non-steroidal antiinflammatory agent
0,318  0,019  Antialcoholic
0,307  0,009  Carcinogenic, group 1
0,337  0,041  Cardiodepressant
0,381  0,086  Antineoplastic (breast cancer)
0,329  0,035  DNA synthesis inhibitor
0,331  0,038  Vascular (periferal) disease treatment
0,314  0,022  VCAM1 expression inhibitor
0,298  0,006  Estrogen antagonist
0,336  0,045  DNA damaging
0,302  0,012  Toxic, respiratory center
0,292  0,002  Antidote, mercury
0,314  0,026  P-glycoprotein inhibitor
0,307  0,020  Skeletal muscle relaxant
0,339  0,054  CYP1A2 substrate
0,298  0,013  Acetylcholinesterase inhibitor
0,339  0,055  Radioprotector
0,318  0,035  Antineoplastic (bladder cancer)
0,358  0,075  CYP3A4 substrate
0,287  0,005  Triose-phosphate isomerase inhibitor
0,298  0,017  Genotoxic
0,327  0,046  Cytostatic
0,300  0,022  Diuretic
0,368  0,092  Antibacterial
0,313  0,039  Antiparasitic
0,328  0,056  Sodium/bile acid cotransporter inhibitor
0,278  0,006  VEGF expression inhibitor
0,275  0,005  Estrogen agonist
0,278  0,008  5 Hydroxytryptamine 3E antagonist
0,273  0,003  Premenstrual syndrome treatment
0,307  0,038  Antineoplastic (sarcoma)
0,271  0,005  Argininosuccinate synthase inhibitor
0,311  0,046  Antiglaucomic
0,314  0,050  Insulysin inhibitor
0,270  0,007  Antineoplastic, alkylator
0,284  0,022  Interferon gamma antagonist
0,279  0,018  Nitric-oxide synthase stimulant
0,302  0,041  Cyclic AMP phosphodiesterase inhibitor
0,293  0,033  Antihypotensive
0,266  0,006  Phosphodiesterase 4D inhibitor
0,313  0,053  Chemoprotective
0,327  0,068  Vasodilator, coronary
0,326  0,068  CYP2D6 substrate
0,262  0,005  Growth stimulant
0,328  0,072  Antineoplastic (colorectal cancer)
0,263  0,009  GABA C receptor rho-2 antagonist
0,258  0,006  Movement disorders treatment
0,255  0,005  Arachidonic acid antagonist
0,254  0,004  Estrogen receptor beta agonist
0,318  0,070  Antineoplastic (colon cancer)
0,273  0,025  UGT1A3 substrate
0,253  0,006  GABA C receptor antagonist
0,271  0,025  Tumour necrosis factor antagonist
0,258  0,012  Bronchodilator
0,249  0,005  Interleukin 12 antagonist
0,276  0,031  Urinary incontinence treatment
0,253  0,009  SULT1A1 substrate
0,281  0,038  Sedative
0,270  0,028  I kappa B kinase epsilon inhibitor
0,267  0,026  Anesthetic
0,253  0,012  Phobic disorders treatment
0,245  0,005  Antineoplastic alkaloid
0,252  0,013  Carcinogenic, group 2B
0,282  0,043  5 Hydroxytryptamine 1E antagonist
0,244  0,007  Antiprotozoal (Babesia)
0,292  0,055  Proliferative diseases treatment
0,246  0,009  Antispirochetal
0,261  0,025  Antiviral (West Nile virus)
0,273  0,038  Antihelmintic
0,241  0,006  5 Hydroxytryptamine 3A agonist
0,310  0,075  Antifungal
0,237  0,002  Anesthetic inhalation
0,237  0,005  Phosphodiesterase 4C inhibitor
0,256  0,024  CNS active muscle relaxant
0,241  0,010  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,240  0,010  Antirickettsial
0,238  0,009  Contraceptive female
0,275  0,046  Chemopreventive
0,291  0,063  Antihypercholesterolemic
0,246  0,019  Aldehyde dehydrogenase inhibitor
0,281  0,054  Cytotoxic
0,289  0,062  Transcription factor STAT inhibitor
0,307  0,081  Apoptosis antagonist
0,258  0,033  CYP2B6 inhibitor
0,230  0,005  Thioredoxin inhibitor
0,285  0,061  Transcription factor STAT3 inhibitor
0,234  0,011  Constipation treatment
0,250  0,028  Antiparkinsonian, tremor relieving
0,271  0,049  Mutagenic
0,237  0,017  Cystathionine beta-synthase inhibitor
0,231  0,011  Adenylate kinase inhibitor
0,266  0,047  Nitric oxide antagonist
0,245  0,026  Phospholipase C inhibitor
0,224  0,005  GABA C receptor rho-1 antagonist
0,227  0,010  Opioid antagonist
0,290  0,072  Antineoplastic (multiple myeloma)
0,246  0,029  3C-like protease (Human coronavirus) inhibitor
0,288  0,071  Hypoxia-inducible factor 1 alpha inhibitor
0,319  0,103  CYP2C9 inhibitor
0,328  0,112  15-Lipoxygenase inhibitor
0,220  0,007  Carcinogenic, group 2A
0,288  0,075  Spasmolytic
0,220  0,007  Adenylate cyclase stimulant
0,278  0,068  CYP1A2 inhibitor
0,276  0,067  Amyotrophic lateral sclerosis treatment
0,226  0,019  Antitussive
0,307  0,100  Stroke treatment
0,284  0,079  Antineoplastic (ovarian cancer)
0,228  0,023  Uterine stimulant
0,211  0,007  Phosphodiesterase 3A inhibitor
0,266  0,063  Acute neurologic disorders treatment
0,288  0,086  12-Lipoxygenase inhibitor
0,230  0,028  Antidote
0,211  0,010  NADH dehydrogenase inhibitor
0,211  0,010  Phosphofructokinase-1 inhibitor
0,268  0,068  Antipyretic
0,207  0,008  Keratolytic
0,207  0,009  Antiviral (Influenza B)
0,202  0,004  UGT2B11 substrate
0,206  0,009  Pregnane X receptor agonist
0,214  0,017  Antiviral (Poxvirus)
0,212  0,015  Choleretic
0,221  0,025  Antifungal enhancer
0,210  0,014  Menstruation disorders treatment
0,233  0,037  Antihelmintic (Nematodes)
0,212  0,017  Microtubule formation inhibitor
0,233  0,039  Antianorexic
0,200  0,007  DOPA decarboxylase inhibitor
0,299  0,107  Cognition disorders treatment
0,202  0,011  Antihelmintic (Fasciola)
0,198  0,007  T cell inhibitor
0,221  0,031  Aldehyde oxidase substrate
0,223  0,033  NOS3 expression enhancer
0,196  0,007  Glutamate decarboxylase inhibitor
0,193  0,005  Opioid kappa receptor agonist
0,278  0,089  Antineoplastic (osteosarcoma)
0,251  0,062  Antineoplastic (glioblastoma multiforme)
0,206  0,018  CF transmembrane conductance regulator agonist
0,197  0,009  Opioid mu receptor antagonist
0,199  0,013  Histidine decarboxylase inhibitor
0,190  0,004  Ca2+-transporting ATPase inhibitor
0,226  0,041  Age-related macular degeneration treatment
0,210  0,025  Mannose-6-phosphate isomerase inhibitor
0,284  0,100  Antithrombotic
0,189  0,005  Acetylcholine release stimulant
0,187  0,006  Anabolic
0,311  0,133  Analgesic
0,274  0,096  CYP3A4 inhibitor
0,195  0,019  Anticataract
0,193  0,017  Hearing loss treatment
0,189  0,013  Opioid delta receptor antagonist
0,215  0,039  Antipruritic
0,285  0,109  Antileukemic
0,214  0,039  Antiviral (Ebola)
0,212  0,037  Protein kinase stimulant
0,189  0,015  Androgen antagonist
0,183  0,008  Carbamoyl phosphate synthetase inhibitor
0,215  0,042  LDLR expression enhancer
0,225  0,052  Focal adhesion kinase 2 inhibitor
0,199  0,027  Raynaud's phenomenon treatment
0,194  0,023  Antiprotozoal (Trichomonas)
0,208  0,038  Melanin inhibitor
0,180  0,011  Analgesic, opioid
0,173  0,004  Narcotic antagonist
0,202  0,034  Hexokinase inhibitor
0,244  0,078  Antidiabetic symptomatic
0,184  0,018  Interleukin 8 antagonist
0,202  0,036  ATPase inhibitor
0,257  0,093  Immunostimulant
0,172  0,009  Antifungal (Pneumocystis)
0,180  0,016  HIV-1 integrase (Overall Integration) inhibitor
0,205  0,042  Antiviral (Influenza A)
0,180  0,017  Antiinfertility, female
0,207  0,044  Antiviral (Herpes)
0,177  0,014  Posttraumatic stress disorder treatment
0,213  0,051  Histone acetyltransferase inhibitor
0,185  0,023  Antihelmintic (Trematoda)
0,181  0,019  NAT2 substrate
0,212  0,051  Antiviral (Hepatitis)
0,186  0,025  Cyclooxygenase 3 inhibitor
0,195  0,035  Antiprotozoal (Coccidial)
0,197  0,037  Bone formation stimulant
0,164  0,005  CDC25B inhibitor
0,188  0,029  Toll-Like receptor 2 antagonist
0,181  0,023  Liver cirrhosis treatment
0,167  0,009  Phosphodiesterase 4A inhibitor
0,169  0,013  Toll-Like receptor 4 antagonist
0,179  0,023  Coagulant
0,161  0,005  Mineralocorticoid receptor antagonist
0,168  0,013  Glutamate dehydrogenase inhibitor
0,199  0,044  Amylase inhibitor
0,179  0,024  GABA receptor agonist
0,189  0,035  Cell wall synthesis inhibitor
0,168  0,014  Electrolyte absorption antagonist
0,211  0,059  Hepatoprotectant
0,186  0,034  Neurotrophic factor
0,180  0,029  Cathepsin H inhibitor
0,232  0,082  Urologic disorders treatment
0,181  0,032  Cholesterol synthesis inhibitor
0,176  0,028  Sphingosine 1-phosphate receptor 5 antagonist
0,158  0,010  NAT1 substrate
0,178  0,031  Antieczematic
0,176  0,031  Adenylate cyclase inhibitor
0,157  0,012  Aromatase inhibitor
0,162  0,017  Actinic keratosis treatment
0,169  0,025  Alcohol dehydrogenase substrate
0,173  0,029  Aminopeptidase B inhibitor
0,167  0,023  UGT2B1 substrate
0,174  0,030  Antiprotozoal (Amoeba)
0,154  0,011  Female sexual dysfunction treatment
0,162  0,018  Carbonic anhydrase VI inhibitor
0,161  0,018  Prolactin inhibitor
0,162  0,021  Antiviral (Papilloma)
0,186  0,045  Heat shock protein 90 antagonist
0,188  0,050  Antiviral (Hepatitis C)
0,143  0,005  Aldosterone antagonist
0,151  0,014  Paget's disease treatment
0,145  0,009  Glycine receptor antagonist
0,145  0,009  Acyl-CoA dehydrogenase inhibitor
0,140  0,004  Aconitate hydratase inhibitor
0,161  0,026  Heat shock protein 70 antagonist
0,160  0,026  Photosensitizer
0,137  0,004  Antidote, organophosphates
0,136  0,003  Progesterone agonist
0,181  0,048  Neurotensin receptor agonist
0,209  0,076  MAP kinase kinase 2 inhibitor
0,152  0,019  Potassium channel activator
0,140  0,007  Granulocyte macrophage colony stimulating factor agonist
0,161  0,029  Sphingosine 1-phosphate receptor 2 antagonist
0,143  0,010  Biliverdin reductase inhibitor
0,144  0,011  Glutamate release inhibitor
0,166  0,034  Antismoking
0,140  0,008  Androgen agonist
0,223  0,092  Calpain inhibitor
0,155  0,023  Chronic obstructive bronchitis treatment
0,142  0,012  Sigma receptor antagonist
0,155  0,026  Sulfotransferase substrate
0,217  0,090  Antiprotozoal (Leishmania)
0,135  0,007  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,165  0,039  Antihyperlipoproteinemic
0,131  0,006  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,154  0,030  Mucolytic
0,190  0,065  Sigma receptor agonist
0,217  0,093  Neuropeptide Y2 antagonist
0,159  0,035  Antineoplastic antimetabolite
0,131  0,008  Acetylcholine M5 receptor agonist
0,137  0,015  Restless leg syndrome treatment
0,194  0,072  DNA methyltransferase I inhibitor
0,128  0,006  Antimycoplasmal
0,155  0,034  Falcipain 3 inhibitor
0,129  0,008  Sleep apnea treatment
0,233  0,112  Lipoxygenase inhibitor
0,143  0,024  Phosphodiesterase IV inhibitor
0,138  0,020  SULT1E1 substrate
0,161  0,043  Monophenol monooxygenase inhibitor
0,129  0,013  Acetylcholine muscarinic agonist
0,144  0,028  Catalase inhibitor
0,128  0,012  Cushing's syndrome treatment
0,129  0,013  GABA aminotransferase inhibitor
0,119  0,004  Calcium channel P-type blocker
0,148  0,033  DNA repair enzyme inhibitor
0,149  0,034  Butyrylcholinesterase inhibitor
0,196  0,082  DNA methylase inhibitor
0,135  0,020  Histamine N-methyltransferase inhibitor
0,127  0,013  Na+ K+ transporting ATPase inhibitor
0,162  0,048  Antiseptic
0,121  0,008  Phosphodiesterase 3B inhibitor
0,141  0,028  Sphingomyelinase inhibitor
0,257  0,144  Calpain 2 inhibitor
0,131  0,018  Tocolytic
0,175  0,063  Muscular dystrophy treatment
0,124  0,011  Glycine receptor agonist
0,116  0,004  Hypogonadism treatment
0,148  0,035  Shock treatment
0,139  0,027  Arylamine N-Acetyltransferase substrate
0,207  0,096  Antineoplastic (cervical cancer)
0,233  0,122  Hepatic disorders treatment
0,130  0,020  GABA A receptor agonist
0,115  0,005  MAP kinase kinase 7 inhibitor
0,141  0,031  Transcription factor STAT6 inhibitor
0,132  0,023  Mental retardation treatment
0,128  0,020  Ornithine decarboxylase inhibitor
0,143  0,036  TRPA1 agonist
0,148  0,041  Vanilloid 1 agonist
0,115  0,008  Antiviral (Parainfluenza)
0,174  0,067  Heat shock protein 90 alpha antagonist
0,157  0,050  Psychosexual dysfunction treatment
0,113  0,007  Glutamate (mGluR6) antagonist
0,124  0,018  Aminopeptidase I inhibitor
0,136  0,030  Acetylcholine agonist
0,155  0,050  Cocaine dependence treatment
0,109  0,004  Adenylate cyclase 1 inhibitor
0,125  0,020  Glutathione S-transferase inhibitor
0,110  0,005  SULT2A1 substrate
0,109  0,004  Dihydroorotate oxidase inhibitor
0,189  0,085  Insulin sensitizer
0,165  0,062  Acetylcholine M1 receptor antagonist
0,127  0,024  Glutamate (mGluR7) agonist
0,136  0,034  Carbonic anhydrase III inhibitor
0,107  0,005  Antihemophilic
0,125  0,023  Inducible nitric-oxide synthase inhibitor
0,114  0,013  Purinergic P2X1 antagonist
0,154  0,052  NADPH oxidase inhibitor
0,149  0,047  Alkylator
0,150  0,049  Retinoprotector
0,137  0,036  Carbonic anhydrase XV inhibitor
0,188  0,088  Pyruvate kinase inhibitor
0,105  0,004  Glucose-6-phosphate isomerase inhibitor
0,107  0,007  Glutamate (mGluR7) antagonist
0,122  0,022  Bromodomain-containing protein 2 inhibitor
0,111  0,011  Acetylcholine M1 receptor agonist
0,118  0,018  mTOR complex 2 inhibitor
0,118  0,019  Phenylalanine 4-hydroxylase inhibitor
0,106  0,007  Exportin-1 inhibitor
0,172  0,073  Liver fibrosis treatment
0,234  0,135  Prostaglandin dehydrogenase inhibitor
0,103  0,005  Lipocortins synthesis agonist
0,109  0,011  Vanilloid 4 agonist
0,104  0,008  Estrogen receptor alpha agonist
0,140  0,043  Sphingosine 1-phosphate receptor 4 antagonist
0,109  0,013  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,101  0,006  Postcoital contraceptive
0,154  0,059  Neuropeptide Y1 antagonist
0,109  0,014  Anticholelithogenic
0,105  0,009  5-Alpha-reductase inhibitor
0,099  0,004  Pregnane X receptor antagonist
0,205  0,110  Antioxidant
0,125  0,031  Alcohol dehydrogenase inhibitor
0,120  0,027  CYP2A6 inhibitor
0,105  0,011  S-adenosyl-L-methionine decarboxylase inhibitor
0,098  0,005  Potassium channel (Inward rectifier) activator
0,122  0,029  Tourette's syndrome treatment
0,152  0,059  MAO inhibitor
0,112  0,020  Thioredoxin reductase inhibitor
0,195  0,103  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,100  0,008  Potassium channel Kv1.3 blocker
0,154  0,063  Antineoplastic (squamous cell carcinoma)
0,143  0,052  Anesthetic local
0,095  0,005  Potassium channel (ATP-sensitive) activator
0,107  0,017  Estrogen-related receptor beta agonist
0,115  0,026  Antileprosy
0,132  0,044  Expectorant
0,101  0,014  Phospholipase D inhibitor
0,092  0,005  Glucocorticoid antagonist
0,146  0,059  Nav1.6 sodium channel blocker
0,098  0,011  Heat shock protein 90 beta antagonist
0,100  0,013  Opioid agonist
0,151  0,066  Hemostatic
0,172  0,087  Wound healing agent
0,182  0,097  Anticonvulsant
0,108  0,023  Estrogen receptor alpha antagonist
0,103  0,019  CC chemokine 5 receptor agonist
0,122  0,038  Antineoplastic antibiotic
0,114  0,031  NAD(P)H dehydrogenase (quinone) inhibitor
0,124  0,041  Antiprotozoal (Toxoplasma)
0,088  0,005  5-Alpha-reductase 2 inhibitor
0,207  0,124  Antineurogenic pain
0,115  0,033  Antiviral (Rhinovirus)
0,135  0,054  Gastritis treatment
0,086  0,004  Sodium-dependent vitamin C transporter 2 inhibitor
0,150  0,069  Thiol protease inhibitor
0,118  0,037  MAP kinase kinase 1 inhibitor
0,153  0,073  Cytidine deaminase inhibitor
0,126  0,047  Nav1.5 sodium channel blocker
0,104  0,025  D-Ala-D-Ala ligase inhibitor
0,115  0,036  Lanosterol 14 alpha demethylase inhibitor
0,097  0,019  GABA B receptor agonist
0,083  0,005  Dopamine D5 agonist
0,117  0,040  Nitric-oxide synthase inhibitor
0,143  0,067  Toll-Like receptor 9 antagonist
0,109  0,034  Acetylcholine nicotinic antagonist
0,258  0,183  Alpha-glucosidase inhibitor
0,088  0,013  MDM2 inhibitor
0,206  0,132  Antiepileptic
0,088  0,013  Potassium channel intermediate-conductance Ca-activated blocker
0,101  0,028  Interferon agonist
0,180  0,107  Antineoplastic enhancer
0,102  0,030  Nicotinic alpha4beta2 receptor antagonist
0,145  0,073  Antianemic
0,135  0,063  Antihemorrhagic
0,082  0,011  Progesterone antagonist
0,080  0,009  Ryanodine receptor antagonist
0,099  0,028  CDC25A inhibitor
0,076  0,005  5-Alpha-reductase 1 inhibitor
0,130  0,060  Antiviral (Hepatitis B)
0,132  0,062  CC chemokine 6 receptor antagonist
0,121  0,052  MAO A inhibitor
0,217  0,148  Antineoplastic (lung cancer)
0,106  0,037  Bile acid receptor antagonist
0,089  0,021  Protease 3C (Human rhinovirus) inhibitor
0,175  0,107  Antiulcerative
0,196  0,128  Antineoplastic (melanoma)
0,075  0,008  Cholesterol esterase inhibitor
0,097  0,031  Caspase 7 inhibitor
0,122  0,057  Caspase 3 inhibitor
0,087  0,022  Protein kinase C beta inhibitor
0,070  0,004  Kainate receptor agonist
0,099  0,035  Antibiotic
0,089  0,024  NMDA receptor agonist
0,088  0,023  NMDA receptor glycine site agonist
0,084  0,020  Ornithine carbamoyltransferase inhibitor
0,069  0,005  Glucose-6-phosphate dehydrogenase inhibitor
0,107  0,043  Calcium antagonist
0,068  0,004  Vanilloid 3 antagonist
0,133  0,070  Phosphodiesterase inhibitor
0,068  0,005  Glutamate (mGluR8) agonist
0,145  0,082  Pulmonary hypertension treatment
0,076  0,013  Alpha-mannosidase inhibitor
0,071  0,008  Fumarate hydratase inhibitor
0,106  0,044  Protein kinase C zeta inhibitor
0,109  0,047  Breast cancer-resistant protein inhibitor
0,110  0,049  Antifungal (Aspergillus)
0,084  0,023  Gaucher disease treatment
0,115  0,054  AMP-activated protein kinase stimulant
0,133  0,073  Alkaline phosphatase inhibitor
0,067  0,006  Guanylate cyclase inhibitor
0,068  0,008  Cytokine production stimulant
0,078  0,018  Corticotropin releasing factor 2 receptor antagonist
0,082  0,023  Interferon inducer
0,067  0,009  Antihyperaldosteronism
0,082  0,024  Uterine relaxant
0,073  0,015  Glutamate (mGluR group I) agonist
0,069  0,011  Histamine H2 receptor agonist
0,066  0,008  Alpha 1d adrenoreceptor agonist
0,109  0,051  Obsessive-compulsive disorder treatment
0,066  0,008  Membrane dipeptidase inhibitor
0,082  0,024  Antidote, heavy metal
0,087  0,030  Phosphodiesterase III inhibitor
0,070  0,013  Glutamate (mGluR5) agonist
0,082  0,025  5 Hydroxytryptamine 3 agonist
0,110  0,054  Gastric antisecretory
0,072  0,016  Nicotinic alpha3beta2 receptor antagonist
0,080  0,025  NMDA 2C receptor antagonist
0,071  0,016  Topoisomerase II beta inhibitor
0,061  0,007  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,105  0,051  Interleukin 1 beta converting enzyme inhibitor
0,064  0,010  Geranyltranstransferase inhibitor
0,086  0,032  Carbonic anhydrase VA inhibitor
0,062  0,009  GABA uptake inhibitor
0,075  0,022  Cyclin D1 inhibitor
0,139  0,087  MAP kinase 3 inhibitor
0,082  0,029  Endocannabinoid uptake inhibitor
0,082  0,030  Potassium channel (Tandem pore domain) blocker
0,127  0,075  Toll-Like receptor antagonist
0,060  0,008  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,119  0,067  Autism spectrum disorders treatment
0,060  0,009  Potassium channel Kv1.1 blocker
0,202  0,152  Metabolic disease treatment
0,062  0,013  Dopamine beta hydroxylase inhibitor
0,056  0,007  Estrone sulfatase inhibitor
0,066  0,016  Squalene epoxidase inhibitor
0,105  0,056  Xanthine oxidase inhibitor
0,070  0,022  Sphingosine kinase 2 inhibitor
0,063  0,015  Mannosidase inhibitor
0,065  0,017  Immunoglobulin Fc receptor antagonist
0,097  0,049  Phosphodiesterase I inhibitor
0,071  0,024  Heme oxygenase stimulant
0,092  0,044  Sodium/hydrogen exchanger 5 inhibitor
0,092  0,044  Histamine H2 receptor antagonist
0,056  0,008  Delayed rectifier potassium channel blocker
0,073  0,026  Transcription factor RelA inhibitor
0,081  0,034  Secretase beta inhibitor
0,058  0,012  Retinoid X alpha receptor agonist
0,072  0,026  Carbonic anhydrase VB inhibitor
0,089  0,044  Carbonic anhydrase XIII inhibitor
0,054  0,009  Peptide deformylase inhibitor
0,055  0,010  Glutamate (mGluR3) antagonist
0,080  0,035  Carbonic anhydrase V inhibitor
0,053  0,008  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,115  0,070  Proteasome inhibitor
0,103  0,058  Antiemetic
0,069  0,024  Cannabinoid CB2 receptor antagonist
0,073  0,029  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,057  0,013  Antiviral (Enterovirus)
0,062  0,019  Phosphodiesterase 7A inhibitor
0,111  0,067  Myasthenia Gravis treatment
0,115  0,072  Acetylcholine muscarinic antagonist
0,063  0,020  Lysophosphatidic acid 3 receptor antagonist
0,081  0,038  Benzodiazepine agonist
0,053  0,010  Heme oxygenase inhibitor
0,062  0,019  Estradiol 17 beta-dehydrogenase inhibitor
0,069  0,026  Sphingosine kinase inhibitor
0,098  0,056  Phosphodiesterase 6D inhibitor
0,047  0,004  Nicotinic acid receptor 2 antagonist
0,057  0,015  Glutamate (mGluR4) antagonist
0,121  0,080  Antibacterial (Helicobacter pylori)
0,071  0,030  Cyclin-dependent kinase 6 inhibitor
0,056  0,015  Thymidine kinase inhibitor
0,067  0,026  Protein 50S ribosomal subunit inhibitor
0,054  0,013  Arginase inhibitor
0,065  0,024  Nicotinic receptor alpha7 subunit antagonist
0,062  0,022  Prolyl endopeptidase inhibitor
0,078  0,037  Bulimia treatment
0,195  0,155  Antimycobacterial
0,062  0,023  Opioid mu receptor agonist
0,054  0,014  Nerve growth factor antagonist
0,067  0,028  Botulinum neurotoxin type A inhibitor
0,060  0,021  Adenosine deaminase inhibitor
0,094  0,055  Polo-like kinase-1 inhibitor
0,045  0,007  Glutamate (mGluR3) agonist
0,116  0,078  MAP kinase kinase inhibitor
0,054  0,016  GABA B receptor antagonist
0,200  0,162  Thyroid hormone antagonist
0,043  0,005  Purinergic P2Y15 antagonist
0,057  0,020  Carbonic anhydrase IV inhibitor
0,053  0,016  Retinoid X receptor agonist
0,076  0,039  Neuronal nicotinic receptor antagonist
0,070  0,033  Narcolepsy treatment
0,041  0,005  GRP78 expression inhibitor
0,059  0,022  Antiviral (Herpesvirus 3, Human)
0,072  0,036  Hyperparathyroidism treatment
0,115  0,079  Cholinergic antagonist
0,053  0,018  Glutamate (mGluR group III) antagonist
0,041  0,005  Prostaglandin F2 alpha agonist
0,053  0,018  Glutamate (mGluR1a) antagonist
0,051  0,017  Histamine H1 receptor agonist
0,055  0,021  Oxytocin agonist
0,161  0,127  Aryl hydrocarbon receptor agonist
0,074  0,040  Phosphodiesterase 4B inhibitor
0,048  0,014  Retinoid X receptor antagonist
0,112  0,078  Acetylcholine antagonist
0,039  0,006  Glutamate (mGluR1a) agonist
0,042  0,009  Nicotinic alpha3beta4 receptor agonist
0,037  0,005  Vanilloid 2 agonist
0,119  0,087  Skin whitener
0,191  0,158  CYP2D6 inhibitor
0,131  0,099  Phospholipase A2 inhibitor
0,060  0,029  Leukotriene C antagonist
0,033  0,002  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,053  0,022  Purinergic P2X4 antagonist
0,106  0,076  5 Hydroxytryptamine 2B antagonist
0,046  0,016  Nicotinic acid receptor agonist
0,059  0,029  Epithelial sodium channel blocker
0,036  0,006  Hedgehog signaling activator
0,043  0,013  Tubulin agonist
0,042  0,012  Retinoid X alpha receptor antagonist
0,052  0,022  Dihydroorotase inhibitor
0,040  0,011  Epoxide hydrolase 1 inhibitor
0,103  0,074  Multidrug resistance-associated protein 1 inhibitor
0,042  0,013  Tryptophan 5 hydroxylase inhibitor
0,046  0,017  Farnesoid X receptor agonist
0,040  0,012  Poly(ADP-ribose) polymerase 2 inhibitor
0,065  0,037  Histone deacetylase SIRT3 inhibitor
0,040  0,012  Uridine phosphorylase inhibitor
0,034  0,007  Glucosylceramidase stimulant
0,063  0,035  Phosphodiesterase 1A inhibitor
0,043  0,016  RNA-directed RNA polymerase inhibitor
0,030  0,003  Telomerase stimulant
0,059  0,033  GABA receptor antagonist
0,065  0,038  Phosphodiesterase 1C inhibitor
0,063  0,037  Adenosine A1 receptor antagonist
0,036  0,010  Nicotinic alpha4beta2 receptor agonist
0,095  0,069  Protein kinase (CK2) inhibitor
0,053  0,028  HCV NS3/NS4A protease inhibitor
0,039  0,014  Adenosine uptake inhibitor
0,060  0,035  Fatty acid synthase inhibitor
0,033  0,008  Glutamate (mGluR1) agonist
0,030  0,004  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,054  0,029  CD45 antagonist
0,039  0,014  GABA transporter 3 inhibitor
0,066  0,041  Beta 3 adrenoreceptor antagonist
0,039  0,014  Prostaglandin agonist
0,054  0,029  Potassium channel (Inward rectifier) blocker
0,189  0,164  Thyroid hormone beta antagonist
0,059  0,034  5 Hydroxytryptamine 7 agonist
0,029  0,004  Vesicular glutamate transport inhibitor
0,030  0,006  Antibiotic Quinolone-like
0,074  0,049  Cathepsin G inhibitor
0,090  0,066  MAO B inhibitor
0,028  0,004  Antibiotic Anthracycline-like
0,034  0,011  Prostaglandin EP2 agonist
0,063  0,040  Cannabinoid CB1 receptor agonist
0,056  0,033  NMDA 2A receptor antagonist
0,106  0,083  Beta amyloid protein antagonist
0,062  0,039  Carbonic anhydrase stimulant
0,038  0,015  ATP citrate lysase inhibitor
0,095  0,072  Urease inhibitor
0,097  0,074  Beta glucuronidase inhibitor
0,100  0,077  Protein kinase C gamma inhibitor
0,042  0,020  Inosine monophosphate dehydrogenase inhibitor
0,186  0,164  Antipsoriatic
0,048  0,026  Nicotinic receptor alpha3 subunit antagonist
0,174  0,152  Antituberculosic
0,068  0,046  Sphingosine 1-phosphate receptor 4 agonist
0,064  0,042  5 Hydroxytryptamine 2A agonist
0,031  0,009  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,030  0,009  Acid ceramidase inhibitor
0,036  0,014  Hypoxanthine phosphoribosyltransferase inhibitor
0,024  0,002  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,037  0,016  Nucleoside transporters inhibitor
0,026  0,005  Nicotinic acid receptor 1 antagonist
0,026  0,005  Carbonic anhydrase VIII inhibitor
0,026  0,005  Carbonic anhydrase X inhibitor
0,037  0,016  HCV NS5B polymerase inhibitor
0,050  0,029  Microtubule stabilization
0,037  0,017  Melatonin receptor 1A agonist
0,146  0,125  Antimitotic
0,024  0,004  Thromboxane A2 agonist
0,048  0,027  Potassium channel small-conductance Ca-activated blocker
0,037  0,017  Protein kinase (CK2) beta inhibitor
0,032  0,012  Estrogen-related receptor gamma antagonist
0,042  0,023  Histone deacetylase 9 inhibitor
0,076  0,057  Glutamate receptor agonist
0,032  0,013  Methionyl aminopeptidase 2 inhibitor
0,076  0,057  Macrophage migration inhibitory factor inhibitor
0,025  0,007  Retinoid X beta receptor antagonist
0,056  0,037  Glucosylceramidase inhibitor
0,043  0,025  Sphingosine kinase 1 inhibitor
0,026  0,007  Neuraminidase (Influenza B) inhibitor
0,030  0,011  Lysophosphatidic acid receptor 1 agonist
0,052  0,034  Thromboxane A2 antagonist
0,058  0,040  Glutamate (mGluR1) antagonist
0,041  0,023  5 Hydroxytryptamine 2B agonist
0,105  0,087  Calcium channel N-type blocker
0,054  0,036  GABA A receptor antagonist
0,102  0,084  DNA polymerase I inhibitor
0,027  0,009  Corticosteroid-like
0,030  0,013  Sodium/glucose cotransporter 2 inhibitor
0,062  0,044  Phosphodiesterase VII inhibitor
0,086  0,069  Potassium channel (Ca-activated) activator
0,059  0,042  Potassium channel (Ca-activated) blocker
0,029  0,012  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,059  0,042  Prostaglandin EP2 antagonist
0,054  0,037  Thromboxane antagonist
0,250  0,233  MAP kinase 1 inhibitor
0,040  0,023  Histone deacetylase 7 inhibitor
0,077  0,061  Acetylcholine nicotinic agonist
0,061  0,045  I kappa B kinase 2 inhibitor
0,031  0,015  Lysine carboxypeptidase inhibitor
0,022  0,006  NMDA receptor phencyclidine site antagonist
0,027  0,012  Complement factor 1s inhibitor
0,041  0,026  Cholesterol absorption inhibitor
0,036  0,020  Sirtuin 2 inhibitor
0,045  0,030  NMDA receptor subunit 3B antagonist
0,047  0,032  Carbonic anhydrase VII inhibitor
0,112  0,098  Cytokine production inhibitor
0,023  0,008  Prostaglandin EP4 agonist
0,025  0,011  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,033  0,018  Lysophosphatidic acid 2 receptor antagonist
0,021  0,007  CXC chemokine 5 receptor antagonist
0,070  0,056  Orexin receptor 1 antagonist
0,049  0,035  Bombesin 2 receptor antagonist
0,057  0,043  Sphingosine 1-phosphate receptor 3 antagonist
0,038  0,024  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,024  0,011  Hexokinase stimulant
0,050  0,036  Diacylglycerol O-acyltransferase inhibitor
0,061  0,047  Beta 2 adrenoreceptor agonist
0,070  0,057  Acetylcholine M4 receptor antagonist
0,027  0,014  Sodium/glucose cotransporter inhibitor
0,028  0,015  Thymidine phosphorylase inhibitor
0,046  0,034  CC chemokine 4 receptor antagonist
0,051  0,039  Histamine agonist
0,017  0,005  Antineoplastic (insulinoma)
0,020  0,008  Methylmalonyl-CoA mutase inhibitor
0,039  0,027  Leukotriene C4 antagonist
0,017  0,005  Glutamate (mGluR6) agonist
0,042  0,030  Glutamate (mGluR group III) agonist
0,053  0,041  Carbonic anhydrase I inhibitor
0,094  0,082  Protein kinase (CK2) alpha inhibitor
0,033  0,021  Methionyl aminopeptidase 1 inhibitor
0,037  0,025  Integrin alpha2 antagonist
0,030  0,018  MAP3K8 inhibitor
0,025  0,014  Prostaglandin E2 agonist
0,088  0,077  Dementia treatment
0,023  0,012  Imidazoline I1 receptor antagonist
0,161  0,150  Myocardial infarction treatment
0,017  0,006  Lysophosphatidic acid receptor 3 agonist
0,034  0,023  Free fatty acid receptor 1 antagonist
0,086  0,075  Vascular dementia treatment
0,027  0,017  Integrin alpha2beta1 antagonist
0,035  0,025  Ceramide glucosyltransferase inhibitor
0,039  0,029  Dihydropteroate synthase inhibitor
0,016  0,006  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,071  0,061  Topoisomerase II alpha inhibitor
0,039  0,030  Toll-Like receptor 2 agonist
0,015  0,006  Cyclin D2 inhibitor
0,021  0,012  Inosine monophosphate dehydrogenase 2 inhibitor
0,030  0,021  Acetylcholine M4 receptor agonist
0,067  0,058  Epoxide hydrolase inhibitor
0,041  0,032  Angiotensin AT1 receptor antagonist
0,028  0,019  Antibiotic Naphthyridine-like
0,043  0,034  Phosphorylase inhibitor
0,034  0,025  Phosphoglycerate kinase inhibitor
0,066  0,057  Telomerase inhibitor
0,021  0,012  Vesicular acetylcholine transporter inhibitor
0,090  0,082  Mediator release inhibitor
0,068  0,059  Peroxisome proliferator-activated receptor gamma antagonist
0,032  0,024  Dipeptidyl peptidase II inhibitor
0,057  0,049  Cannabinoid CB1 receptor antagonist
0,023  0,014  Protease (Human cytomegalovirus) inhibitor
0,051  0,043  Carbonic anhydrase II inhibitor
0,048  0,040  5 Hydroxytryptamine 2 agonist
0,078  0,070  Myeloperoxidase inhibitor
0,042  0,034  AICAR transformylase inhibitor
0,019  0,012  Alpha 2b adrenoreceptor agonist
0,017  0,010  Vitamin D receptor agonist
0,020  0,012  Progesterone receptor B antagonist
0,090  0,082  Antifungal (Candida)
0,013  0,005  Thromboxane agonist
0,017  0,010  Nicotinic alpha4 receptor agonist
0,012  0,005  Progesterone receptor A antagonist
0,021  0,014  Factor XIII inhibitor
0,022  0,016  Isoleucine-tRNA ligase inhibitor
0,051  0,045  Matrix metalloproteinase (membrane-type) inhibitor
0,016  0,010  Purinergic P2Y1 agonist
0,058  0,052  Dopamine D1 antagonist
0,037  0,032  AMPA 4 receptor antagonist
0,008  0,003  Transcortin receptor antagonist
0,031  0,026  Calcitonin receptor agonist
0,021  0,015  GABA transporter inhibitor
0,050  0,045  Heparanase inhibitor
0,037  0,032  MAP3K5 inhibitor
0,095  0,091  Topoisomerase II inhibitor
0,059  0,055  Aryl hydrocarbon receptor antagonist
0,029  0,025  Potassium channel small-conductance Ca-activated activator
0,025  0,020  Thyroid hormone agonist
0,026  0,022  LFA antagonist
0,032  0,028  Glucose-dependent insulinotropic receptor agonist
0,116  0,112  Farnesoid X receptor antagonist
0,018  0,014  Complement factor D inhibitor
0,009  0,005  Folate transporter 1 inhibitor
0,123  0,119  Neuropathy treatment
0,031  0,027  Carboxypeptidase B inhibitor
0,031  0,027  Vanilloid 4 antagonist
0,013  0,009  Glucocorticoid agonist
0,008  0,005  DNA topoisomerase III inhibitor
0,074  0,070  I kappa B kinase inhibitor
0,045  0,042  CC chemokine receptor 2B antagonist
0,024  0,021  CXC chemokine 2 receptor antagonist
0,006  0,003  P2 nucleoside transporter inhibitor
0,034  0,031  NMDA receptor subunit 3A antagonist
0,026  0,023  Thrombin receptor antagonist
0,012  0,010  Carbonic anhydrase XI inhibitor
0,017  0,014  Cyclin T1 inhibitor
0,054  0,051  Carbonic anhydrase inhibitor
0,011  0,009  Purine nucleoside phosphorylase inhibitor
0,062  0,060  Cannabinoid receptor antagonist
0,047  0,045  Cannabinoid CB2 receptor agonist
0,053  0,051  Collagenase 3 inhibitor
0,031  0,029  Glutamate (mGluR4) agonist
0,023  0,021  Sigma 2 receptor antagonist
0,015  0,013  GABA transporter 1 inhibitor
0,016  0,014  Alpha 2a adrenoreceptor agonist
0,031  0,029  Carnitine palmitoyltransferase 1 inhibitor
0,035  0,034  Antiviral (Bovine viral diarrhea virus)
0,051  0,050  Alpha 1 adrenoreceptor agonist
0,055  0,053  Cannabinoid receptor agonist
0,025  0,024  Motilin receptor antagonist
0,025  0,024  Baculoviral IAP repeat-containing protein 4 inhibitor
0,055  0,055  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,021  0,021  ICAM 1 antagonist
0,006  0,005  CC chemokine 6 receptor agonist
0,013  0,012  Proline transporter inhibitor
0,078  0,078  Antischistosomal
0,037  0,037  Leukocyte elastase inhibitor

